Skip to main content

ADVERTISEMENT

economic burden

Original Contribution
10/25/2022

Michael Butzner, DrPH, MPH1;  Martin S. Maron, MD2a;  Phil Sarocco, MSc1;  Chia-Chen Teng, MS3;  Eric Stanek, PharmD3;  Hiangkiat Tan, BS3;  Laura A. Robertson, MD4b

Michael Butzner, DrPH, MPH1;  Martin ...
Patients with obstructive hypertrophic cardiomyopathy (oHCM) and severe refractory symptoms may require invasive septal reduction therapies (SRTs), either surgical septal myectomy (SM) or transcatheter alcohol septal ablation (ASA). The main...
Patients with obstructive hypertrophic cardiomyopathy (oHCM) and severe refractory symptoms may require invasive septal reduction therapies (SRTs), either surgical septal myectomy (SM) or transcatheter alcohol septal ablation (ASA). The main...
Patients with obstructive...
10/25/2022
Journal of Invasive Cardiology